Not Tagged
orum therapeutics
[]
orum therapeutics unveils new program at #aacr23, highlighting cbl-b inhibitor-pd-1 conjugate, and presents new data supporting clinical development of two gspt1 programs #immunooncology #targetedproteindegradation #cancer #oncology 
Orum is a private, clinical stage biotech advancing first-in-class tumor-directed, antibody-enabled targeted protein degraders to improve #cancer treatment.